234 related articles for article (PubMed ID: 10737163)
1. 'Carbonyl stress' and dialysis-related amyloidosis.
Miyata T; Ueda Y; Saito A; Kurokawa K
Nephrol Dial Transplant; 2000; 15 Suppl 1():25-8. PubMed ID: 10737163
[TBL] [Abstract][Full Text] [Related]
2. Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis (Review).
Sugiyama S; Miyata T; Inagi R; Kurokawa K
Int J Mol Med; 1998 Nov; 2(5):561-5. PubMed ID: 9858652
[TBL] [Abstract][Full Text] [Related]
3. Implication of carbonyl stress in long-term uraemic complications.
Wada T; Miyata T; Kurokawa K
Nephrol Dial Transplant; 1999; 14 Suppl 1():79-81. PubMed ID: 10048461
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
Miyata T; Inagi R; Kurokawa K
Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
[TBL] [Abstract][Full Text] [Related]
5. Oxidative protein damage with carbohydrates and lipids in uremia: 'Carbonyl stress'.
Inagi R; Miyata T
Blood Purif; 1999; 17(2-3):95-8. PubMed ID: 10449866
[TBL] [Abstract][Full Text] [Related]
6. Carbonyl stress: increased carbonyl modification of tissue and cellular proteins in uremia.
Miyata T; Izuhara Y; Sakai H; Kurokawa K
Perit Dial Int; 1999; 19 Suppl 2():S58-61. PubMed ID: 10406495
[TBL] [Abstract][Full Text] [Related]
7. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.
Miyata T; van Ypersele de Strihou C; Kurokawa K; Baynes JW
Kidney Int; 1999 Feb; 55(2):389-99. PubMed ID: 9987064
[TBL] [Abstract][Full Text] [Related]
8. AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications.
Zoccali C; Mallamaci F; Tripepi G
Nephrol Dial Transplant; 2000; 15 Suppl 2():7-11. PubMed ID: 11051031
[TBL] [Abstract][Full Text] [Related]
9. Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid.
Ehlerding G; Schaeffer J; Drommer W; Miyata T; Koch KM; Floege J
Nephrol Dial Transplant; 1998 Jun; 13(6):1465-75. PubMed ID: 9641177
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity.
Miyata T; Saito A; Kurokawa K; van Ypersele de Strihou C
Nephrol Dial Transplant; 2001; 16 Suppl 4():8-11. PubMed ID: 11402090
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and management of dialysis-related amyloid bone disease.
Nangaku M; Miyata T; Kurokawa K
Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
[TBL] [Abstract][Full Text] [Related]
12. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").
Miyata T; Sugiyama S; Saito A; Kurokawa K
Kidney Int Suppl; 2001 Feb; 78():S25-31. PubMed ID: 11168978
[TBL] [Abstract][Full Text] [Related]
13. Relevance of oxidative and carbonyl stress to long-term uremic complications.
Miyata T; Kurokawa K; van Ypersele de Strihou C
Kidney Int Suppl; 2000 Aug; 76():S120-5. PubMed ID: 10936808
[TBL] [Abstract][Full Text] [Related]
14. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
15. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure.
Miyata T; Maeda K; Kurokawa K; van Ypersele de Strihou C
Nephrol Dial Transplant; 1997 Feb; 12(2):255-8. PubMed ID: 9132640
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of dialysis-related amyloidosis.
Miyata T; Maeda K
Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):493-7. PubMed ID: 8591057
[TBL] [Abstract][Full Text] [Related]
17. Beta2-microglobulin and renal bone disease.
Wada T; Miyata T; Sakai H; Kurokawa K
Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
[TBL] [Abstract][Full Text] [Related]
18. Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum.
Niwa T; Katsuzaki T; Momoi T; Miyazaki T; Ogawa H; Saito A; Miyazaki S; Maeda K; Tatemichi N; Takei Y
Kidney Int; 1996 Mar; 49(3):861-7. PubMed ID: 8648931
[TBL] [Abstract][Full Text] [Related]
19. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy.
Miyata T; Sugiyama S; Suzuki D; Inagi R; Kurokawa K
Kidney Int Suppl; 1999 Jul; 71():S54-6. PubMed ID: 10412738
[TBL] [Abstract][Full Text] [Related]
20. Dialysis-related amyloidosis: pathogenesis focusing on AGE modification.
Niwa T
Semin Dial; 2001; 14(2):123-6. PubMed ID: 11264780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]